Prestige Consumer Healthcare (PBH) Deferred Taxes (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Deferred Taxes of $3.6 million for Q4 2025, up 23.44% year-over-year from $2.9 million in Q4 2024, and down 79.31% quarter-over-quarter from $17.4 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Deferred Taxes (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Deferred Taxes history runs 16 years deep, the most recent figure standing at $3.6 million for Q4 2025.
- In Q4 2025, Deferred Taxes rose 23.44% year-over-year to $3.6 million; the TTM figure through Dec 2025 stood at $33.9 million (up 119.58% YoY), while the FY2025 annual figure was $14.4 million, down 37.54% from the prior year.
- Deferred Taxes for Q4 2025 stood at $3.6 million, down from $17.4 million in the prior quarter.
- The five-year high for Deferred Taxes was $17.4 million in Q3 2025, with the low at -$74.8 million in Q1 2023.
- The 5-year median for Deferred Taxes is $4.0 million (2023), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes sank 5578.51% in 2023, then soared 852.12% in 2025.
- Prestige Consumer Healthcare's Deferred Taxes stood at $3.7 million in 2021, then surged by 168.25% to $9.8 million in 2022, then slumped by 47.29% to $5.2 million in 2023, then plunged by 43.65% to $2.9 million in 2024, then climbed by 23.44% to $3.6 million in 2025.
- Business Quant data shows PBH's Deferred Taxes at $3.6 million in Q4 2025, $17.4 million in Q3 2025, and $5.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 25.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -33.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 25.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -124.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -25.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.60 Mn |
| Sep 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 5.83 Mn |
| Mar 31, 2025 | 7.13 Mn |
| Dec 31, 2024 | 2.91 Mn |
| Sep 30, 2024 | 3.75 Mn |
| Jun 30, 2024 | 612,000.00 |
| Mar 31, 2024 | 8.18 Mn |
| Dec 31, 2023 | 5.17 Mn |
| Sep 30, 2023 | 5.45 Mn |
| Jun 30, 2023 | 4.27 Mn |
| Mar 31, 2023 | -74.79 Mn |
| Dec 31, 2022 | 9.81 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 1.21 Mn |
| Mar 31, 2022 | -1.32 Mn |
| Dec 31, 2021 | 3.66 Mn |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 5.88 Mn |
| Mar 31, 2021 | 10.66 Mn |